Systems Analysis of Stress-adapted Cancer Organelles (SASCO) Center
应激适应癌症细胞器系统分析 (SASCO) 中心
基本信息
- 批准号:10703471
- 负责人:
- 金额:$ 208.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-12 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAneuploidyAutomobile DrivingCancer BiologyCancer ModelCell Culture TechniquesCell membraneCellsCellular biologyChargeChromosomesChronicClinical and Translational Science AwardsCollaborationsColorectal CancerComplexCouplesCultured CellsDataDecision MakingDedicationsDefectDiseaseEcosystemEducationElementsEpidermal Growth Factor ReceptorEukaryotaFacultyFosteringGenetically Engineered MouseGenomicsGlioblastomaGoalsGrowthImageImmunofluorescence ImmunologicIndirect ImmunofluorescenceInstitutionJointsKRAS2 geneLeadLeadershipLengthLesionLifeMalignant NeoplasmsMalignant neoplasm of brainMentorshipMetabolicMetaphaseMetastatic Neoplasm to the LiverMitochondriaMitoticModelingMutationNCI Center for Cancer ResearchNeoplasm MetastasisOncogene ActivationOncogenesOncogenicOrganellesPathway interactionsPhasePhenotypePilot ProjectsPlayPositioning AttributePrimary NeoplasmProcessProliferatingRecordsRecurrenceResearchResearch PersonnelResearch Project GrantsResolutionResource SharingResourcesRestRoleSecondary toSignal TransductionSite VisitStandardizationStressStructureSystemSystems AnalysisSystems BiologyTestingTrainingUniversitiesVirginiaVisioncancer cellcancer typecareercell typeclinical practicecostexperimental studyfeature detectionfeature extractionimage registrationinnovationinteroperabilitylearning strategymalignant breast neoplasmmitochondrial membranemultidisciplinarymutantoutreachprogramsrepairedresidenceresponsesuccesssummer researchtranscription factortumortumorigenesisundergraduate research experience
项目摘要
PROJECT SUMMARY/ABSTRACT
Oncogene activation is modulated by normal subcellular compartments that execute specialized functions
related to hallmark cancer phenotypes. These organelles must adapt to oncogenic stress in order for tumors
to initiate and progress, but there is little to no systems-level understanding of how such adaptations occur and
what vulnerabilities might be created. The Systems Analysis of Stress-adapted Cancer Organelles (SASCO)
Center at the University of Virginia will address this challenge by mechanistic modeling of organellar processes
that iterates with quantitative experiments in disease-relevant cell cultures and primary tumors. The working
SASCO Center hypothesis is that organelle-specific adaptation to oncogenic stress occurs through a few
critical bottlenecks, which become identifiable once the relevant signaling, metabolic, and transport pathways
have been properly integrated. The Center brings together 14 investigators with primary and collaborative
track records in cancer biology, systems biology, genetically engineered mouse models of cancer, and clinical
practice. Three Research Projects and one Shared Research Core will pursue a common research strategy,
which leverages mechanistic models to test competing alternative hypotheses about how organelles adapt to
stresses from proximal oncogenes that drive specific types of cancer. The Projects are organized
hierarchically as organelle stresses downstream of proliferation-inducing oncogenes. Project 1 will examine
the chromosome passenger complex and its regulated phase separation during metaphase as an organelle
that senses and repairs spindle defects to suppress breast cancer aneuploidy driven by mitotic transcription
factors. Project 2 will evaluate the metabolic consequences of chronic mitochondrial fragmentation caused by
mutant KRAS in primary colorectal cancers and secondary liver metastases. Project 3 will investigate localized
signal-transduction rebalancing as a mechanism for alleviating plasma-membrane stress caused by EGFR
amplification in glioblastoma. All Research Projects will rely on the High-Content Imaging & Analysis Core to
obtain iterative multichannel immunofluorescence data with organelle-level resolution and quantification. The
SASCO Outreach Core amplifies ongoing programs at the University of Virginia to provide summer research
experiences for undergraduates and faculty scholars from historically underrepresented backgrounds as well
as introductory systems biology modeling materials for clinicians across the Commonwealth of Virginia. The
SASCO Center will thus create a national headquarters for subcellular cancer systems biology within the
broader Cancer Systems Biology Consortium.
项目概要/摘要
癌基因激活由执行特殊功能的正常亚细胞区室调节
与标志性癌症表型相关。这些细胞器必须适应致癌应激才能产生肿瘤
来启动和进展,但对这种适应如何发生和进行的系统级了解很少甚至没有
可能会产生哪些漏洞。应激适应癌症细胞器的系统分析 (SASCO)
弗吉尼亚大学中心将通过细胞器过程的机械建模来应对这一挑战
迭代与疾病相关的细胞培养物和原发性肿瘤的定量实验。工作中
SASCO 中心的假设是,细胞器对致癌应激的特异性适应是通过一些因素发生的。
关键瓶颈,一旦相关信号、代谢和运输途径被识别,这些瓶颈就变得可识别
已正确集成。该中心汇集了 14 名主要和协作研究人员
跟踪癌症生物学、系统生物学、基因工程小鼠癌症模型和临床的记录
实践。三个研究项目和一个共享研究核心将追求共同的研究策略,
它利用机械模型来测试关于细胞器如何适应的竞争性替代假设
来自驱动特定类型癌症的近端癌基因的压力。项目已组织
细胞器强调增殖诱导癌基因的下游。项目1将检查
染色体过客复合物及其在中期作为细胞器调节的相分离
感知并修复纺锤体缺陷,以抑制由有丝分裂转录驱动的乳腺癌非整倍性
因素。项目 2 将评估慢性线粒体碎片引起的代谢后果
原发性结直肠癌和继发性肝转移中的突变 KRAS。项目3将调查本地化
信号转导再平衡作为缓解 EGFR 引起的质膜应激的机制
胶质母细胞瘤的扩增。所有研究项目都将依赖高内涵成像和分析核心
获得具有细胞器级分辨率和定量的迭代多通道免疫荧光数据。这
SASCO Outreach Core 扩大了弗吉尼亚大学正在进行的项目,提供夏季研究
来自历史上代表性不足的背景的本科生和教职学者的经历
作为弗吉尼亚州临床医生的介绍性系统生物学建模材料。这
因此,SASCO 中心将在该领域内创建一个亚细胞癌症系统生物学国家总部。
更广泛的癌症系统生物学联盟。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin A Janes其他文献
Kevin A Janes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin A Janes', 18)}}的其他基金
Interdisciplinary Training in Systems & Biomolecular Data Science
系统跨学科培训
- 批准号:
10631096 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
Open phase-separation models for cancer systems biology
癌症系统生物学的开放相分离模型
- 批准号:
10829012 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10737809 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10366411 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
A synthetic systems biology approach to predict context-specific mechanisms for SHP2 functional activity and resistance to SHP2 inhibition
一种合成系统生物学方法,用于预测 SHP2 功能活性和 SHP2 抑制抗性的特定机制
- 批准号:
10831287 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10540784 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
Interdisciplinary Training in Systems & Biomolecular Data Science
系统跨学科培训
- 批准号:
10411477 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
相似国自然基金
非整倍体对卵巢癌免疫微环境的影响及其作为免疫治疗增效靶点的研究
- 批准号:82373401
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
肿瘤非整倍体悖论的新机制
- 批准号:82372721
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
生长激素通过JAK2/SHP2/ERK1/2通路降低老龄鼠卵母细胞非整倍体率的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
纺锤体组装检查点功能异常在胶质瘤非整倍体形成中的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
非整倍体百合雌雄育性差异的细胞与分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Open phase-separation models for cancer systems biology
癌症系统生物学的开放相分离模型
- 批准号:
10829012 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
A synthetic systems biology approach to predict context-specific mechanisms for SHP2 functional activity and resistance to SHP2 inhibition
一种合成系统生物学方法,用于预测 SHP2 功能活性和 SHP2 抑制抗性的特定机制
- 批准号:
10831287 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
Systems Analysis of Stress-adapted Cancer Organelles (SASCO) Center
应激适应癌症细胞器系统分析 (SASCO) 中心
- 批准号:
10525280 - 财政年份:2022
- 资助金额:
$ 208.14万 - 项目类别:
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
优化低级别神经胶质瘤分子进化发现的参与(OPTIMUM)
- 批准号:
10294462 - 财政年份:2021
- 资助金额:
$ 208.14万 - 项目类别:
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
优化低级别神经胶质瘤分子进化发现的参与(OPTIMUM)
- 批准号:
10491794 - 财政年份:2021
- 资助金额:
$ 208.14万 - 项目类别: